Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: A meta-analysis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Xu, Qiumei ^b   Yuan, Fangfen ^a   Shen, Xuemei ^a   Wen, Hui ^b   Li, Wei ^b   Cheng, Bei ^b   Wu, Jing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELES; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NADPH OXIDASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84894280949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084251     Document Type: Review

References (50)

1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A, et al. (2010) Growing epidemic of coronary heart disease in low- and middle-income countries. Current Problems in Cardiology 35: 72-115.
2. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3: e442.
3. McKay J, Mensah GA, Greenlund K, Mendis S (2004) The atlas of heart disease and stroke. World Health Organization. 405 p.
4. San JG, Fortuno A, Beloqui O, Diez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clinical Science (London) 114: 173-182. (Pubitemid 351293993)
5. Epstein FH, Diaz MN, Frei B, Vita JA, Keaney JF (1997) Antioxidants and atherosclerotic heart disease. New England Journal of Medicine 337: 408-416. (Pubitemid 27328371)
6. Singh U, Jialal I (2006) Oxidative stress and atherosclerosis. Pathophysiology 13: 129-142.
7. Fortuno A, José GS, Moreno MU, Díez J, Zalba G (2005) Oxidative stress and vascular remodelling. Experimental Physiology 90: 457-462. (Pubitemid 40980145)
8. Mueller CF, Laude K, McNally JS, Harrison DG (2005) Redox mechanisms in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 25 : 274-278. (Pubitemid 40189145)
9. Mohazzab K, Kaminski PM, Wolin MS (1994) NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. American Journal of Physiology-Heart and Circulatory Physiology 266: H2568-H2572. (Pubitemid 24215893)
10. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD (P) H oxidase role in cardiovascular biology and disease. Circulation Research 86: 494-501. (Pubitemid 30165039)
11. Sumimoto H, Hata K, Mizuki K, Ito T, Kage Y, et al. (1996) Assembly and activation of the phagocyte NADPH oxidase specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. Journal of Biological Chemistry 271: 22152-22158. (Pubitemid 26303847)
12. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK (1996) P22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin iiinduced hypertrophy in vascular smooth muscle cells. Journal of Biological Chemistry 271: 23317-23321. (Pubitemid 26314775)
13. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, et al. (1999) Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100: 1494-1498. (Pubitemid 29461459)
14. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH (1990), Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. Journal of Clinical Investigation 86: 1729-1737. (Pubitemid 20372627)
15. Whitehead AS, FitzGerald GA (2001) Twenty-first century phox: not yet ready for widespread screening. Circulation 103: 7-9. (Pubitemid 32050427)
16. Guzik TJ, West N, Black EJ, McDonald E, Ratnatunga D (2000) Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102: 1744-1747.
17. de Boer M, de Klein A, Hossle JP, Seger R, Corbeel L, et al (1992) Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). American Journal of Human Genetics 51: p. 1127-1135.
18. Bedard K, Attar H, Bonnefont J, Jaquet V, Borel C, et al. (2009) Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Human Mutation 30: 1123-1133.
19. Schirmer M, Hoffmann M, Kaya E, Tzvetkov M, Brockmöller J (2007) Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity. The Pharmacogenomics Journal 8: 297-304.
20. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, et al. (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97: 135-137. (Pubitemid 28124668)
21. Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, et al. (2006) C242T Polymorphism in CYBA gene (p22 phox and risk of coronary artery disease in a population of Caucasian Italians. Disease Markers 22: 167-173. (Pubitemid 43893795)
22. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W (1999) The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145: 315-323. (Pubitemid 29359140)
23. Lau J, Loannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Annals of Internal Medicine 127: 820-826. (Pubitemid 27465551)
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. British Medical Journal 327: 557-560. (Pubitemid 37088507)
25. Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21: 1539-1558. (Pubitemid 34746062)
26. Hedges LV, Vevea JL (1998) Fixed-and random-effects models in meta-analysis. Psychological Methods 3: 486-504.
27. Thompson SG, Higgins J (2002) How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine 21: 1559-1573. (Pubitemid 34746063)
28. Patsopoulos NA, Evangelou E, Loannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. International Journal of Epidemiology 37: 1148-1157.
29. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315: 629-634. (Pubitemid 27387172)
30. Stanger O, Renner W, Khoschsorur G, Rigler B, Wascher TC (2001) NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clinical Physiology 21: 718-722. (Pubitemid 33114710)
31. Zafari AM, Davidoff MN, Austin H, Valppu L, Cotsonis G, et al. (2002) The A640G and C242T p22 phox polymorphisms in patients with coronary artery disease. Antioxidants and Redox Signaling 4: 675-680. (Pubitemid 35001452)
32. Saha N, Sanghera D, Kamboh M (1999) The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. European Journal of Clinical investigation 29: 999-1002.
33. Cai H, Duarte N, Wilcken DEL, Wang XL (1999) NADH/NADPH oxidase p22 phax C242T polymorphism and coronary artery disease in the Australian population. European Journal of Clinical Investigation 29: 744-748. (Pubitemid 29425515)
34. Li A, Prasad A, Mincemoyer R,Satorius C, Epstein N, et al. (1999) Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. American Journal of Medical Genetics 86: 57-61. (Pubitemid 29387717)
35. Lee WH, Hwang TH, Oh GT, Kwon S, UkCho YH, et al. (2001) Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vascular Medicine 6: 103-108. (Pubitemid 32791511)
36. Yamada Y, Izawa H, Ichihara S, Ishihara H, Hirayama H, et al. (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. New England Journal of Medicine 347: 1916-1923. (Pubitemid 35429921)
37. Mata-Balaguer T, de la Herrán R, Ruiz-Rejón C, Ruiz-Rejón M, Garrido-Ramos MA, et al. (2004) Angiotensin-converting enzyme and p22 (phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population. International Journal of Cardiology 95: 145-151. (Pubitemid 38757619)
38. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, et al. (2004) Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. European Heart Journal 25: 970-977. (Pubitemid 38857871)
39. Fan M, Kahonen M, Rontu R, Lehtinen R, Viik J, et al.(2006) The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study. American Heart Journal 152: 538-42.
40. He MA, Cheng LX, Jiang CZ, Zeng HS, Wang J, et al. (2007) Associations of polymorphism of P22(phox) C242T, plasma levels of vitamin E, and smoking with coronary heart disease in China. American Heart Journal 153 : 640. e1-640. e6.
41. Morgan TM, Krumholz HM, Lifton RP, Spertus JA (2007) Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. the Journal of the American Medical Association 297: 1551-1561.
42. Niemiec P, Zak I, Wita K (2007) The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coronary Artery Disease 18: 339-346. (Pubitemid 47186833)
43. Macias-Reyes A, Rodriguez-Esparragon F, Caballero-Hidalgo A, Hernandez- Trujillo Y, Medina A, et al.(2008) Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radical Research 42: 82-92. (Pubitemid 351372194)
44. Nikitin AG, Chistiakov DA, Minushkina LO, Zateyshchikov DA, Nosikov VV, et al. (2010) Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart and Vessels 25: 229-236.
45. Goliasch G, Wiesbauer F, Grafl A, Ponweiser E, Blessberger H, et al. (2011) The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤40 years of age). Thrombosis and Haemostasis 105: 529-534.
46. Najafi M, Alipoor B, Shabani M, Amirfarhangi A, Ghasemi H, et al. (2012) Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD (P) H oxidase p22phox gene and severity of stenosis in coronary arteries. Gene 499: 213-217.
47. Niemiec P, Nowak T, Balcerzyk A, Krauze J, Zak I (2011) The CYBA gene A640G polymorphism influences predispositions to coronary artery disease through interactions with cigarette smoking and hypercholesterolemia. Biomarkers 16: 405-412.
48. Di Castelnuovo A, Soccio M, Iacoviello L, Evangelista V, Consoli A, et al. (2008) The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb Haemost 99: 594-601. (Pubitemid 351549297)
49. Fang S, Wang L, Jia C (2010) Association of p22phox gene C242T polymorphism with coronary artery disease: A meta-analysis. Thrombosis Research 125: e197-e201.
50. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, et al. (2004) C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43: 1246-1251. (Pubitemid 38696914)